BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2001
View Archived Issues
Sterix raises funds for R&D programs
Read More
Human growth hormone peptide analogue under active development for obesity
Read More
Copper/zinc chelator may address underlying cause of Alzheimer's disease
Read More
AstraZeneca selects tradename for investigational anticoagulant
Read More
Mechanism of blood pressure-lowering effects of PPARgamma agonists studied using GW-1929
Read More
BioMarin files application to conduct human trials with topical Vibriolysin
Read More
Amgen launches ARANESP in the E.U.
Read More
Beneficial effects of insulin sensitizer on lipoprotein abnormalities in db/db mice
Read More
Ligand and TAP establish R&D alliance for SARMs
Read More
EntreMed and NEI study Panzem in age-related macular degeneration
Read More
Efficacy and safety of COL-1621 demonstrated in men with testosterone deficiency
Read More
Zycos and Aventis Pasteur extend drug discovery alliance
Read More
Medarex and Epicyte to codevelop therapeutic antibodies
Read More
New GH receptor antagonist may have a role in the management of colon cancer
Read More
Phase I/II trial begins for malignant melanoma vaccine
Read More
NicOx and Biolipox to codevelop NO-releasing respiratory therapies
Read More
New, orally active PTP1B inhibitor lowers plasma glucose and insulin levels in ob/ob mice
Read More
Phase I/II bladder cancer trial shows 59% complete response rate on MCC therapy
Read More
International Psoriasis Symposium selected by MedImmune to present phase I results for MEDI-507
Read More
Profile of novel SERM indicates potential in both osteoporosis and endometriosis
Read More
Inhibitors of proteases such as cathepsin K and methods of use
Read More
Oligobenzimidazoles discovered by Aventis to be useful for DNA transfection
Read More
Orally active antifungal agents patented by Toagosei
Read More
Novel antiallergic agents in the Taisho pipeline
Read More
Chemokine antagonists claimed for wide series of conditions in recent patent
Read More